COVID-19 Funding Opportunities
University of Kentucky Internal Pilot Funding
- UK CURE - COVID-19 Pilot Program, Core 3- Social Sciences
- The University of Kentucky Center for Clinical and Translational Sciences - UK CURE COVID-19 Pilot Program
- UK CURE - COVID-19 Pilot Program, Core 2-Materials/Methods
Biomedical Advanced Research and Development Authority (BARDA)
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Ammendment 19 (COVID-19 Areas of Interest) Deadline: October 31, 2020
- Special Instructions 009 Issuance for Easy Broad Agency Announcement (EZ-BAA) BAA-20-100-SOL-0002
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) Amendment 17 (COVID-19 Areas of Interest) Deadline: October 31, 2020
Christopher and Dana Reeve Foundation (CDRF)
- Quality of Life Grants Program - COVID-19 Grant- Deadline 10/13/20
epartment of Commerce / Economic Development Administration
Department of Defense/MTEC
- Potential Topics of Upcoming Funding Opportunities in 2020
- Medical CBRN Defense Consortium (MCDC) Other Transaction Agreement (OTA) Request for Information (RFI) – CoV Pandemic Response
Department of Health and Human Services
Office of the Assistant Secretary for Health
Emergent Ventures
Multi-Agency - Operation Warp Speed
- Broad Agency Announcement (BAA) Supporting Research for the U.S. Department of Health and Human Services Under Contracts, Other Transaction Agreements and Technology Investment Agreements for the Treatment and Protection from COVID-19- Deadline: August 01, 2022.
National Institutes of Health
- NIH - Notice of Special Interest (NOSI) – Research on Rehabilitation Needs Associated with the COVID-19 Pandemic - Deadline 05/08/23
- NIH - Global Infectious Disease Research Training Program (D43 Clinical Trial Optional) – PAR-20-229 -Deadline 08/03/22
- NIH - Notice of Special Interest (NOSI): The Influence of Host Resilience on Heterogeneity of Acute Respiratory Distress Syndrome/Acute Lung Injury (ARDS/ALI) - NHLBI - Expiration date 07/06/24
- NIH - Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 - Expiration date 09/01/21
- Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) (Rolling Deadline) - Expiration date 01/24/21
- NIH/NIAID Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) - Expiration date 07/08/21
- Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (Please note that NOT-AI-20-059 replaces NOT-AI-20-034 which has been rescinded, effective immediately) Deadline: 07/02/2021
- Notice of Special Interest (NOSI): Utilizing Telemedicine or Other Remote-Based Platforms to Develop and Support Treatments for Substance Use Disorders - Expiration date 01/08/24
- Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project. Deadlines: 3/12/21, 7/12/21
- NIH – Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) Deadline: 03/02/2021
- NIH – Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) - PAR-20-237- Deadline: 12/01/2020
- Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need- Deadline 11/11/2020
- NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) - Deadline 07/01/2020, and again the first working day of each month through 02/01/2021
- Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations - Deadline 12/30/2020
- Notice of Special Interest (NOSI): Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 - Deadline 12/30/2020
- Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders - Deadline 09/08/22
- NINDS - Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System - Expiration date 04/15/21
- NIAAA - Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA - Expiration date 04/16/21
- OBSSR, NHLBI, NIA, NIAAA, NIDDK, NIEHS, NCCIH, NCI - Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences - Expiration Date 04/01/21
- Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) - Expiration date 05/04/21
- NIMHD, NIA, NIMH - Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities - Expiration date 05/01/21
- NIMH, NIA, NIAAA, NIMHD - Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus - Expiration date 04/16/21
- NIA, NIMH, NIAAA - Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) - Expiration date 05/01/21
- NCATS - Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) - Expiration date 10/17/20
- NIDA -NIH Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus - Expiration date 03/31/21
- NIAID, NIA - Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) - Expiration date 01/13/23
- NCI, NCCIH, NHGRI, NIAID, NICHD, NIDDK, NIEHS, NIGMS, NIMHD, NIBIB, Common Fund, NCATS, NIAAA - Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) - Expiration date 03/10/23
- NIEHS Mechanism for Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed) - Expiration date 10/03/22
- NIA, NIAID, NIDDK, NIDA, NIMH, NIEHS, NICHD, NIAAA, NIBIB, NHGRI, NIMHD, NCATS, NIDCD, NCI, NIDCR -NIH Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) - Expiration date 01/25/22
National Science Foundation
- NSF 20-052 Dear Colleague Letter on the Coronavirus Disease 2019 (COVID-19)
- Dear Colleague Letter: Request for SBIR/STTR Phase I Proposals Addressing COVID-19
Russell Sage Foundation (RSF)
- Request for articles - the social and political impact of COVID-19 in the US - Deadline 11/03/20